Will Authorised Biologics Deter Biosimilars?—Utilising JFTC’s Expertise in Drug Pricing
Crossref DOI link: https://doi.org/10.1007/978-981-16-7814-1_11
Published Online: 2022-02-08
Published Print: 2022
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abe, Takanori
Text and Data Mining valid from 2022-01-01
Version of Record valid from 2022-01-01
Version of Record valid from 2022-02-08
Chapter History
First Online: 8 February 2022